SCHEMBL6537811

SCHEMBL6537811

O=c1cc[nH]c2c([N+](=O)[O-])ccc(Cl)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
FBP1 P09467 1/20 0.41
CCR8 P51685 1/20 0.40
CASP6 P55212 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 3/20 0.37
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
CES1 P23141 1/20 0.36
VCAM1 P19320 5/20 0.36
KAT2B Q92831 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PARP1 P09874 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537685 0.82 KMT2A (0.41) TDP1CCR8CASP6TSHRMAPK1
SCHEMBL27174894 0.78 TDP1 (0.48) TDP1FBP1CASP6TSHRMAPK1
SCHEMBL30799237 0.78 TDP1 (0.48) TDP1FBP1CASP6TSHRMAPK1
SCHEMBL11003986 0.78 TDP1 (0.48) TDP1FBP1CASP6TSHRMAPK1
SCHEMBL6537669 0.77 LMNA (0.51) TDP1FBP1CASP6KMT2AALDH1A1
SCHEMBL3920360 0.75 TDP1 (0.48) TDP1TSHRMAPK1ALDH1A1VCAM1
SCHEMBL6368215 0.74 CASP6 (0.50) TDP1CCR8CASP6TSHRMAPK1
SCHEMBL20877299 0.74 BCHE (0.43) CCR8CASP6TSHRKMT2AALDH1A1
SCHEMBL6538265 0.74 TDP1 (0.41) TDP1FBP1CASP6TSHRMAPK1
SCHEMBL6537493 0.73 ALDH1A1 (0.58) TDP1FBP1CCR8CASP6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed